Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway (Q46944998)
Jump to navigation
Jump to search
scientific article published on 18 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway |
scientific article published on 18 October 2007 |
Statements
1 reference
Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway (English)
1 reference
Zhou J
1 reference
Pan M
1 reference
Xie Z
1 reference
Loh SL
1 reference
Bi C
1 reference
Tai YC
1 reference
Lilly M
1 reference
Lim YP
1 reference
Han JH
1 reference
Glaser KB
1 reference
Albert DH
1 reference
Davidsen SK
1 reference
Chen CS
1 reference
18 October 2007
1 reference
1 reference
22
1 reference
1
1 reference
138-146
1 reference
Identifiers
1 reference